Verified peer comparison
ImageneBio vs Seres Therapeutics Financial Comparison
Direct answer
ImageneBio and Seres Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free ImageneBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- ImageneBio Revenue
- 800,000 USD
- Seres Therapeutics Revenue
- 789,000 USD
- ImageneBio Operating income
- -48,451,000 USD
- Seres Therapeutics Operating income
- -93,971,000 USD